Background: Early detection of cardiovascular disease in patients with hypertension could initiate appropriate treatment to control blood pressure and prevent the progression of cardiovascular disease. Objective: The goal of this study was to show how impedance cardiography waveform analysis with postural change can be used to detect subclinical cardiovascular disease in patients with high blood pressure. Methods: Patients with high blood pressure had impedance cardiography data obtained in two positions, standing upright and supine. Results: In 50 adults, impedance cardiography indicated that all patients had abnormal data, with 44 (88%) having multiple abnormalities. Impedance cardiography showed 32 (64%) had ventricular dysfunction, 48 (96%) had vascular load abnormalities, 34 (68%) had hemodynamic abnormalities, 2 (4%) had hypovolemia, and 3 (6%) had hypervolemia. Conclusions: Hypertensive patients have diverse cardiovascular abnormalities that can be quantified by impedance cardiography. By stratifying patients with ventricular, vascular, and hemodynamic abnormalities, treatment could be customized based on the abnormal underlying mechanisms with the potential to rapidly control blood pressure, prevent progression of cardiovascular disease, and possibly reverse remodeling.
Introduction
In the United States, one in three adults (74 million) has high blood pressure (BP) [American Heart Association, 2010] . Of those being treated for hypertension (HTN), only 34% have it controlled [Chobanian et al. 2003 ]. From a preventive perspective, it is important to control HTN to reduce the risk of adverse cardiovascular outcomes such as stroke and heart failure (HF) [O'Donnell et al. 2010] . The evidence that HTN can be a precursor of HF is clear. Data from the Acute Decompensated Heart Failure Registry [ADHERE Acute Decompensated Heart Failure National Registry, 2003] show that 73% of acute decompensated HF patients had a medical history of HTN. To stress the progressive nature of HF, an update for the guidelines for the diagnosis and management of HF defines four stages in the evolution of the disease [Hunt et al. 2005 ]. The first two stages are in the asymptomatic phase with the difference being that patients in stage A are at risk but have no heart disorder, whereas patients in stage B have subclinical heart disease.
Rather than just aiming to lower BP, the goal should be to treat the underlying cardiovascular disease (CVD). The early detection of CVD while still in the asymptomatic phase is very beneficial [Smith and Levy, 2008; McMurray et al. 1998 ]. If the causal mechanism could be identified, then therapy tailored to the underlying cause could be initiated with the goal of preventing progression of the disease and possibly reversing remodeling [Albert, 2000] .
HTN can present with a variety of underlying mechanisms. BP is the result of the interaction of ventricular function and vascular load. A person with HTN may have high cardiac output (CO) and/or high systemic vascular resistance (SVR). Other conditions may also exist such as fluid overload or decompensation. Studies indicate that asymptomatic CVD, although frequently present, is often not detected by the typical clinical assessment of a physical examination, electrocardiograph, and chest radiograph [Redfield et al. 2003; Thomas et al. 2002; Davies et al. 2001; Zile et al. 2001; Mosterd et al. 1999; McDonagh et al. 1997; Nishimura and Tajik, 1997; Davie et al. 1996; Stevenson and Perloff, 1989] . It would be useful to have a simple, noninvasive point-of-care test for assessing the underlying mechanisms associated with HTN.
Impedance cardiography (ICG) is a simple noninvasive technique that is commonly used, while the patient is supine, to measure thoracic fluid level and to calculate CO and SVR [Ferrario et al. 2007; Yancy and Abraham, 2003; Bernstein, 1986] . Additional data pertaining to ventricularvascular coupling can be obtained by taking ICG readings with the subject performing a postural change from upright (sitting or standing) to supine and by analyzing the dZ/dt waveform which represents the first derivative of the pulsatile change in thoracic electrical bioimpedance (EB) (Figure 1 ). With a subject in the supine position, the size of the dZ/dt wave during systole, called the E wave, has been shown in studies validated by echocardiography to correlate with left ventricular systolic function (LVSF) DeMarzo et al. , 2005 Antonicelli et al. 1991; Breithaupt et al. 1990; Northridge et al. 1990 ]. During early diastole, the presence of a pronounced wave may indicate diastolic dysfunction Pickett and Buell, 1993] . By noting differences in ICG data between two positions, upright and supine, the Therapeutic Advances in Cardiovascular Disease 5 (3) compensatory response can be assessed DeMarzo et al. 2005; Critchley et al. 2002; Ovsyshcher et al. 1992; Smith et al. 1989; Buell, 1988; Richards and McBrien, 1988; Hubbard et al. 1986 ].
Vascular load consists of resistive and pulsatile loads. SVR can provide a measure of resistive load. Pulsatile load has two components: arterial stiffness and wave reflection [Ooi et al. 2008] . Arterial compliance can be used as an inverse indicator of arterial stiffness [Abdelhammed et al. 2005] . A decrease in arterial compliance has been described as a marker for predicting vascular disease [Resnick et al. 2000; Glasser et al. 1997 ]. Aortic wave reflection increases afterload and, therefore, results in forward flow deceleration [Nichols and O'Rourke, 2005] . On the dZ/dt waveform, this causes a widening of the E wave. This first appears when the subject is upright because of the additional increase in afterload due to gravitational pooling of blood in lower extrathoracic compartments [Braunwald et al. 2001; Tarazi et al. 1970] . The objective of this study was to retrospectively analyze ICG data of hemodynamics and ventricularvascular coupling in 2 positions in adults with high BP to detect the presence of asymptomatic CVD.
Methods
This was a retrospective study of adults who had ICG testing as part of a community wellness screening program conducted in the Dermed Diagnostics Inc. clinic. For the study, inclusion criteria were a systolic BP 140 mmHg and/or a diastolic BP 90 mmHg. The study population consisted of 50 subjects (42% male; average age 60.3±11.6 years).
ICG data were obtained with the subject standing upright and supine. The thoracic EB signal was acquired using the HYPERGRAPH TM computer-based impedance cardiograph (Dermed Diagnostics Inc.) with electrode placement as shown in Figure 2 [DeMarzo and . BP was taken while the subject was supine.
For analytical purposes, the ensemble averaged dZ/dt waveform was viewed as having systolic and diastolic segments (Figure 1 ) . Systolic amplitude (SA) was the height of the ensemble averaged E wave, [dZ/ dt] max (in per second), divided by the average EB of the thorax, Z o (in ). SA is an indicator of left ventricular contractile force [Kubicek, 1989] . The criteria for normal supine LVSF were a triangular E wave and SA 0.03 /s/. Supine ventricular systolic dysfunction was defined as a nontriangular supine E wave or a supine SA <0.03 /s/.
In normal diastole, blood movement in the thorax is significantly less than during systole.
In the diastolic segment of the dZ/dt waveform, the result is usually no wave above the dZ/dt baseline or a small wave in some normal females or athletes. During early diastole, a pronounced diastolic wave (D wave) can be caused by elevated filling pressure or moderate to severe regurgitation . The presence of a pronounced D wave, in either upright or supine position, was considered evidence of diastolic dysfunction. The criterion for a pathologic D wave was a D wave with an amplitude above the dZ/dt baseline greater than one third of the amplitude of the corresponding E wave.
For assessing the compensatory response to postural change, the criterion for normal ventricular function was upright SA less than supine SA. Decompensation was defined as upright SA supine SA, indicating that the left ventricle had lost contractile reserve and was performing contrary to normal function according to Starling's law of the heart [Braunwald et al. 2001] . Decompensation was considered a form of ventricular dysfunction.
With a subject in the supine position, a hemodynamic abnormality was defined as cardiac index (CI; cardiac output divided by body surface area) <2.5 l/min/m 2 , CI > 4.7 l/min/m 2 , or SVR >1500 dyne sec/cm 5 . High SVR was considered an indication of elevated vascular resistive load. The thoracic fluid level was indicated by the fluid index (FI), defined as the nominal vertical distance between leads 2 and 3 (in cm), adjusted for body habitus and sex, divided by Z o [Bernstein, 1986] . Only extremes in thoracic fluid volume were considered to be abnormal [DeMarzo et al. 2002] . The criterion for hypovolemia was FI <0.55 cm/. The criterion for hypervolemia was FI >1.3 cm/. Arterial compliance index (ACI) was defined as supine SA divided by supine pulse pressure. An ACI <0.1 indicated central arterial stiffness [DeMarzo, 2009] .
A normal supine E wave is triangular with a narrow peak. With normal heart function, postural change from supine to upright causes two changes: (1) a decrease in SA; and (2) a slight rounding of the upright E wave peak, due to the higher afterload, with the descending limb of the upright E wave being more convex than the descending limb of the supine E wave (left frames of Figure 3 ). With wave reflection in the aorta, the backward pressure caused by the reflected wave partially offsets the forward pressure from ventricular contraction. During systole, the reduction in net forward pressure reduces the rate of forward movement of blood. This usually first appears as an upright E wave with a pronounced widening or rounding of the peak (top right frame of Figure 3 ). The criteria for augmented wave reflection were an upright E wave with a peak that is significantly rounded on both the ascending and descending limbs or a bifurcated upright E wave.
Results
The overall results are presented in Table 1 . Every subject had at least one ICG abnormality, with an average of 3.3±1.5 per person. Some type of ventricular dysfunction was present in 32 (64%) subjects, vascular load abnormalities were present in 48 (96%) subjects, thoracic fluid level extremes were present in 5 (10%) subjects, and hemodynamic parameters outside of normal ranges were present in 34 (68%) subjects. There were 32 (64%) patients being treated for HTN. Data for this medicated subgroup and for the subgroup of 18 subjects untreated for HTN are shown in Table 1 . A breakdown of BP data by category of ICG abnormality is shown in Table 2 . A breakdown of ICG data by abnormality is shown in Table 3 .
Discussion
The data suggest that subclinical CVD, detectable by ICG, is prevalent in HTN. Approximately two out of three had ventricular dysfunction (supine systolic dysfunction, diastolic dysfunction, and/or decompensation), putting them in stage B in the development of HF. This information may be useful for selecting medications.
The most common abnormality was central arterial stiffness (96%). The ability of the heart to generate flow depends on the interaction of left ventricular contractile force with vascular load. Arterial stiffness causes a reduced buffering capacity which leads to amplification of the reflected wave resulting in augmented afterload and, therefore, increased ventricular workload [Bogren et al. 1989 ]. As vascular load rises, the left ventricle must exert more contractile force to maintain blood flow. This is evident by high pulse pressure. Eventually, the vascular load reaches a level when the left ventricle can exert no more contractile force. This is the onset of decompensation, when the upright SA and supine SA are equal. The ICG data showed one in three subjects with decompensation.
There were two subjects with the only ICG abnormality being high CI. Also, they were the only subjects without central arterial stiffness. Both had elevated SA which correlates with high central aortic pressure [Nagel et al. 1989 ].
The two subjects with hypovolemia had an upright SA that was less than half of the supine SA. They were the only subjects with such a dramatic difference between upright and supine values. Such a drop in SA may suggest insufficient ventricular filling while upright. Of the three subjects with hypervolemia, two had high SVR, and the other had an SVR value near the top of the normal range.
The medicated subgroup showed worse BP control and cardiovascular function than the untreated subgroup. The medicated subgroup had significantly higher systolic BP (p ¼ 0.03) and pulse pressure (p ¼ 0.005). Compared with the untreated group, the medicated group had considerably more patients with ventricular dysfunction (81% versus 33%) including systolic dysfunction (53% versus 28%), diastolic dysfunction (28% versus 6%), and decompensation (41% versus 17%). ICG data were not used in the management of any of the patients in the medicated subgroup.
The data in Table 2 show that subjects with various abnormalities had similar BP values, and the data in Table 3 show that ICG measurements varied considerably by abnormality. This suggests that just BP values may be insufficient for effective CVD management of patients with HTN.
Adding ICG waveform analysis with postural change and arterial compliance to the traditional hemodynamic parameters contributes useful data for assessing the underlying CVD associated with HTN. This information may be useful to stratify patients into subpopulations for selecting appropriate categories of antihypertensive medications.
Limitations
This was a small retrospective study focused on using ICG data to detect the presence of functional abnormalities, ventricular and/or vascular. With ventricular abnormalities, ICG alone is not sufficient for a diagnosis, because some ICG abnormalities can have various underlying mechanisms. For example, a pronounced D wave could be caused by elevated filling pressure, aortic regurgitation, mitral regurgitation or tricuspid regurgitation. For ventricular dysfunction, other modalities, such as echocardiography should be used for diagnosis. Vascular load abnormalities should be diagnosed using other tests including pulse wave analysis and anklebrachial index. After a diagnosis has been made, serial ICG tests can be used to assess patient response to treatment.
Clinical implications
Over 90% of adults diagnosed with HTN are treated with medications [Miller et al. 2010; Moser and Franklin, 2007 ]. Yet, even in the rigorous setting of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), control rates were only 50% at 6 months and 55% at 1 year [Cushman et al. 2002] . A meta-analysis of five published trials showed that ICG values of CI, SVR, and thoracic fluid level, while a patient is supine, have been used to adjust antihypertensive medications by assessing left ventricular performance, quantifying total vascular resistive load, and detecting hypervolemia with a control rate of approximately 67% [Ferrario et al. 2010] . Another large study on using supine ICG data to manage HTN in clinical practice reported a control rate over 85% [Matthews and Magenheim, 2008] .
By adding postural change to assess decompensation and ICG waveform analysis to detect systolic and diastolic dysfunction, asymptomatic patients could be stratified into stages A or B of HF. ICG data on central arterial stiffness and aortic wave reflection may be useful for assessing vascular disease. In addition, SA could be used as an indicator of central aortic pressure. A treating clinician could use this additional ICG data about the underlying mechanisms as a decision aid for selecting the most appropriate antihypertensive medications. For example, if an asymptomatic hypertensive patient with central adiposity has normal ventricular function, elevated SVR, central arterial stiffness, and augmented aortic wave reflection, then a vasodilator such as an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, as indicated for stage A of the HF management guidelines, could be considered for therapy. Another asymptomatic patient with identified ventricular dysfunction would be in stage B and possibly could be considered for beta-blocker therapy. Titration could be guided by patient response to treatment using the initial ICG test as a baseline for comparison with subsequent ICG tests from serial office visits at intervals as short as 2 weeks. If prevention of cardiovascular morbidities and mortalities is a goal, then rapid achievement of BP control is needed to improve cardiovascular outcomes [Basile, 2008] . With this approach, ICG could be useful in achieving BP control in months, while targeting the underlying CVD.
ICG may be helpful in mitigating therapeutic inertia and patient nonadherence to treatment. Having timely information from a point-of-care test that can be performed by a nurse or technician may encourage clinicians to be more aggressive about treating HTN. Abnormal ICG results could serve as a wakeup call to the patient. An intuitive graphic representation of ventricular dysfunction and measurements outside of normal ranges can be powerful tools for motivating patients to adhere to treatment regiments.
Adding a second position and analyzing waveforms enhance the value of ICG for stratifying HTN patients based on ventricular and/or vascular load abnormalities. All considered, ICG with postural change could be an important addition to the standard physical examination for achieving rapid control of HTN, preventing progression of CVD, and possibly reversing remodeling.
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